Transcription Factor IRF7 is Involved in Psoriasis Development and Response to Guselkumab Treatment.

Authors:
Yuan X; Xin T; Yu H; Huang J; Xu Y and 2 more

Journal:
J Inflamm Res

Publication Year: 2024

DOI:
10.2147/JIR.S450048

PMCID:
PMC10876010

PMID:
38375022

Journal Information

Full Title: J Inflamm Res

Abbreviation: J Inflamm Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"table 1 summary of six geo datasets involved in the exploration and validation cohort geo dataset experiment type treatment cohort samples gse51440 expression profiling array guselkumab exploration 20 nl; 22 bl; 9 w1; 8 w12 gse173706 scrna-seq -- exploration 11 pn; 14 pp gse201827 expression profiling array secukinumab validation 139 nl; 95 bl; 47 w12; 25 w40; 41 w52 gse137218 expression profiling array secukinumab validation 14 nl; 14 bl; 14 w1; 14 w2; 14 w12 gse102725 expression profiling array secukinumab validation 10 nl; 10 bl; 10 w16; 5 w32 gse178228 expression profiling array ixekizumab validation 32 bl; 30 w1; 26 w2; 29 w4 note : - the skin samples included in this dataset were not subjected to any form of treatment for psoriasis w1 w2 w4 w12 w16 w32 w40 w52 lesion samples collected at different time points after treatment. all data analysis parameters were set according to the official documentation available on github ( https://github com/sqjin/cellchat )."

Evidence found in paper:

"all data analysis parameters were set according to the official documentation available on github ( https://github com/sqjin/cellchat )."

Evidence found in paper:

"Disclosure The authors declare no competing interests related to this study."

Evidence found in paper:

"This research received no external funding."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025